Tempus

Tempus, a leading technology company based in Chicago, is advancing precision medicine through the practical application of artificial intelligence in healthcare. Founded in 2015, Tempus AI Chicago has built one of the world's largest libraries of clinical and molecular data, along with an operating system that makes this data accessible and useful. As a prominent Tempus company, its mission is to empower healthcare professionals and researchers with cutting-edge tools and insights, enabling them to make data-driven decisions for personalized patient care. Tempus healthcare services include genomic sequencing and the analysis of molecular and therapeutic data to assist physicians in making real-time, data-driven decisions. Their platform integrates and analyzes vast amounts of genomic, transcriptomic, and clinical data to improve health outcomes and accelerate discovery in life sciences. The Tempus company extends its work across multiple disease areas, with a particular focus on oncology, neurology, cardiology, and infectious diseases. In addition to its core services, Tempus AI Chicago offers solutions for clinical trial design and patient matching, as well as tools for real-world evidence generation. The company has developed AI-enabled diagnostics and personalized medicine solutions, with a platform that includes proprietary software and dedicated data pipelines, creating a network of healthcare institutions. Tempus claims to be connected in some way to more than 50% of all oncologists practicing in the United States. The Tempus company has raised over $1.3 billion in funding and expanded its capabilities through strategic acquisitions. Tempus generates revenue through various segments, including genomic sequencing, data licensing, and clinical trial services. While the company has achieved significant scale in terms of revenue, it is not yet profitable. Tempus healthcare continues to innovate in areas such as digital pathology, voice-activated clinical assistants, and institutional data sharing platforms, further solidifying its role as a leader in AI-driven healthcare solutions.